Paracrine receptor activation by microenvironment triggers bypass survival signals and ALK inhibitor resistance in EML4-ALK lung cancer cells

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
Tadaaki YamadaSeiji Yano

Abstract

Cancer cell microenvironments, including host cells, can critically affect cancer cell behaviors, including drug sensitivity. Although crizotinib, a dual tyrosine kinase inhibitor (TKI) of ALK and Met, shows dramatic effect against EML4-ALK lung cancer cells, these cells can acquire resistance to crizotinib by several mechanisms, including ALK amplification and gatekeeper mutation. We determined whether microenvironmental factors trigger ALK inhibitor resistance in EML4-ALK lung cancer cells. We tested the effects of ligands produced by endothelial cells and fibroblasts, and the cells themselves, on the susceptibility of EML4-ALK lung cancer cell lines to crizotinib and TAE684, a selective ALK inhibitor active against cells with ALK amplification and gatekeeper mutations, both in vitro and in vivo. EML4-ALK lung cancer cells were highly sensitive to ALK inhibitors. EGF receptor (EGFR) ligands, such as EGF, TGF-α, and HB-EGF, activated EGFR and triggered resistance to crizotinib and TAE684 by transducing bypass survival signaling through Erk1/2 and Akt. Hepatocyte growth factor (HGF) activated Met/Gab1 and triggered resistance to TAE684, but not crizotinib, which inhibits Met. Endothelial cells and fibroblasts, which produce the...Continue Reading

References

May 24, 1979·Nature·H S KorenJ W Larrick
Mar 4, 2005·The American Journal of Pathology·Hiroki KuniyasuHitoshi Ohmori
Feb 3, 2006·International Journal of Cancer. Journal International Du Cancer·Kunio Matsumoto, Toshikazu Nakamura
Jul 3, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jussi P KoivunenPasi A Jänne
Jul 23, 2008·Proteomics·Kunio MatsumotoToshikazu Nakamura
Oct 11, 2008·Nature Reviews. Cancer·Bostjan SerugaIan F Tannock
Dec 10, 2008·Proceedings of the National Academy of Sciences of the United States of America·Manabu SodaHiroyuki Mano
Mar 13, 2009·Nature Reviews. Cancer·Johanna A Joyce, Jeffrey W Pollard
Aug 12, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Leora Horn, William Pao
Oct 22, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Wei WangSeiji Yano
Dec 17, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Tadaaki YamadaSeiji Yano
Feb 5, 2010·Cancer Cell·Alexa B TurkePasi A Jänne
Jun 17, 2010·Nature Reviews. Clinical Oncology·Filip JankuRazelle Kurzrock
Jun 25, 2010·The New England Journal of Medicine·Makoto MaemondoUNKNOWN North-East Japan Study Group
Jul 21, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Sandra S McAllister, Robert A Weinberg
Oct 29, 2010·The New England Journal of Medicine·Eunice L KwakA John Iafrate
Oct 29, 2010·The New England Journal of Medicine·Young Lim ChoiUNKNOWN ALK Lung Cancer Study Group
Apr 13, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Kazuo YasumotoSeiji Yano
Apr 20, 2011·Proceedings of the National Academy of Sciences of the United States of America·Ryohei KatayamaAlice T Shaw
Sep 29, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Johannes M HeuckmannRoman K Thomas
Nov 5, 2011·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Seiji YanoMasayuki Noguchi
Dec 7, 2011·Cancer Discovery·Anthony C FaberJeffrey A Engelman
Jan 12, 2012·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Robert C DoebeleD Ross Camidge
Jan 27, 2012·Science Translational Medicine·Ryohei KatayamaJeffrey A Engelman

❮ Previous
Next ❯

Citations

Sep 26, 2012·Annals of Oncology : Official Journal of the European Society for Medical Oncology·K A Oien, J L Dennis
Sep 26, 2013·Science Signaling·Matthew J Niederst, Jeffrey A Engelman
Aug 25, 2012·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Kurtis D DaviesRobert C Doebele
Aug 12, 2014·Biochemical Pharmacology·Vito W Rebecca, Keiran S M Smalley
Mar 28, 2013·Evidence-based Complementary and Alternative Medicine : ECAM·Xiao-Hong KangMing-Juan Liao
Sep 25, 2012·Expert Opinion on Drug Discovery·Georg HopfingerOlaf Merkel
Aug 8, 2013·Experimental Lung Research·Ning XiaCheng-ping Hu
Jan 23, 2015·International Journal of Cancer. Journal International Du Cancer·Jagdish MahaleLynne M Howells
Oct 3, 2015·Seminars in Cell & Developmental Biology·Maicol Mancini, Yosef Yarden
May 16, 2014·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Junya NakadeSeiji Yano
Mar 12, 2015·Cancer Cell·Frederick H WilsonLevi A Garraway
Mar 20, 2016·Neoplasia : an International Journal for Oncology Research·Xuyuan DongShaomeng Wang
Nov 19, 2015·Acta Pharmaceutica Sinica. B·Lihua Huang, Liwu Fu
Feb 22, 2014·Cancer Biology & Therapy·Cheng JiXingcong Ren
Dec 4, 2014·The Lancet. Respiratory Medicine·Rafael RosellSai-Hong Ignatius Ou
Apr 29, 2016·Expert Opinion on Emerging Drugs·Janaki SharmaHaiying Cheng
Aug 31, 2016·Annals of Oncology : Official Journal of the European Society for Medical Oncology·I Dagogo-Jack, A T Shaw
Feb 4, 2014·Virchows Archiv : an International Journal of Pathology·John D Hainsworth, F Anthony Greco
Oct 27, 2017·Nature Reviews. Cancer·Julia Rotow, Trever G Bivona
May 27, 2015·World Journal of Biological Chemistry·Yu-Wen Zhang
Sep 4, 2015·Therapeutic Advances in Medical Oncology·Bin-Chi LiaoJames Chih-Hsin Yang
Oct 20, 2017·Science Translational Medicine·Ling ZengDaolin Tang
Feb 20, 2018·Molecular Cancer·Hor-Yue TanYung-Chi Cheng
Feb 17, 2018·Mathematical Medicine and Biology : a Journal of the IMA·Jake P Taylor-KingAndriy Marusyk
Nov 23, 2016·Yonsei Medical Journal·Hyun ChangJong Seok Lee
Mar 5, 2016·Oncotarget·Fabrizio TabbòGiorgio Inghirami
May 5, 2016·Physiological Reviews·Andreas WickiGongda Xue
Apr 13, 2018·Cancers·Ricky M Trigg, Suzanne D Turner
Feb 20, 2019·Nature Ecology & Evolution·Artem KaznatcheevJacob G Scott
Jan 12, 2020·Nature Structural & Molecular Biology·N S PerskyC M Johannessen

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.

Cell Signaling by Tyrosine Kinases

Receptor tyrosine kinases (RTKs) are the high-affinity cell surface receptors for many polypeptide growth factors, cytokines, and hormones. RTKs have been shown not only to be key regulators of normal cellular processes but also to have a critical role in the development and progression of many types of cancer. Discover the latest research on cell signaling and RTK here.

Related Papers

Lung Cancer : Journal of the International Association for the Study of Lung Cancer
Norihiro YamaguchiDaniel Botelho Costa
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
Junko TanizakiKazuhiko Nakagawa
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
Ya-Ting ChenShiu-Feng Huang
Expert Opinion on Pharmacotherapy
Patrick M Forde, Charles M Rudin
© 2021 Meta ULC. All rights reserved